Table 1.
Characteristic | Male (n = 131) | Female (n = 71) | P value |
---|---|---|---|
Height (cm) | 158.83 ± 15.15 | 152.75 ± 5.15 | ns |
Weight (kg) | 68.60 ± 10.18 | 65.20 ± 11.98 | ns |
BMI (kg/m2) | 42.8817 ± 6.46 | 42.95 + 7.59 | ns |
DM (%) | 84 (64.12) | 52 (73.23) | ns |
DM duration (years) | 7.267 ± 11.366 | 9.95 ± 8.28 | ns |
HTN (%) | 100 (76.33) | 63 (88.73) | ns |
HTN duration (years) | 7.805 ± 7.859 | 9.94 ± 9.02 | ns |
Myopathy (%) | 22 (16.79) | 16 (22.53) | ns |
Total cholesterol (mg/dL) | 136.89 ± 37.95 | 138.39 ± 36.80 | ns |
HDL-C (mg/dL) | 40.09 ± 12.06 | 45.32 ± 11.42 | ns |
LDL-C (mg/dL) | 70.93 ± 33.24 | 66.66 ± 34.32 | ns |
VLDL-C (mg/dL) | 31.07 ± 37.36 | 33.22 ± 35.55 | ns |
Triglycerides (mg/dL) | 135.18 ± 72.24 | 126.78 ± 59.60 | ns |
Statin at index | |||
Rosuvastatin, n (%) | 78 (59.54) | 42 (59.15) | ns |
Atorvastatin, n (%) | 55 (41.98) | 28 (39.43) | ns |
DM, diabetes mellitus; HTN, hypertension; HDL-C- high-density lipoprotein cholesterol; LDL-C- low-density lipoprotein cholesterol; VLDL-C- very low-density lipoprotein cholesterol; ns, Not significant; BMI, body mass index.